| 1 | 2332-89-0 | Pymetrozine | | | | |
| 2 | 23321-70-2 | TUNGSTENOXIDEDIHYDRATE | | | | |
| 3 | 23322-64-7 | CERIUM(IV) OXIDE | CeH2O3 | 190.13 | 2600 °C | |
| 4 | 23323-37-7 | 1-deoxy-1-(octylamino)-D-glucitol | C14H31NO5 | 293.4 | 121-124°C(lit.) | |
| 5 | 233233-71-1 | NOMEGESTROL ACETATE:17ALPHA-ACETOXY-6ALPHA-METHYL-19-NOR-PREGN-4,6-DIEN-3,20-DIONE | C23H30O4 | 370.486 | | |
| 6 | 23324-72-3 | METHYLHYDROXYOCTADECADIENOATE | C19H34O3 | 310.47 | | |
| 7 | 23325-09-9 | Tris(dipentyldithiocarbamato-S,S')antimony | C33H66N3S6Sb | 819.04724 | | |
| 8 | 23325-63-5 | bis[2-acetoxybenzoato]copper | C18H14CuO8 | 421.85 | | |
| 9 | 23325-78-2 | CEPHALEXIN MONOHYDRATE | C16H19N3O5S | 365.4 | | 13.5g/L(25 ºC) |
| 10 | 23325-86-2 | Pregn-4-ene-3,20-dione, 17-(3-carboxy-1-oxopropoxy)-9-fluoro-11,21-dihydroxy-, (11β)- (9CI) | C25H33FO8 | 480.52 | | |
| 11 | 233253-68-4 | 1,3-Dioxane,2-(2-ethenylphenyl)-(9CI) | C12H14O2 | 190.24 | | |
| 12 | 233253-90-2 | 1,2-Dimethoxy-4-[(1-methylethoxy)methyl]benzene | | | | |
| 13 | 233254-24-5 | Tomeglovir | C23H27N3O4S | 441.54 | | |
| 14 | 233255-39-5 | Propanamide, 3-hydroxy-2,2-dimethyl-N-[4-[[[5-(methylamino)-1-naphthalenyl]sulfonyl]amino]phenyl]- | C22H25N3O4S | 427.52 | | |
| 15 | 233255-40-8 | 233255-40-8 | | | | |
| 16 | 233255-80-6 | 2-Methoxy-5-[(1-methylethoxy)methyl]phenol | | | | |
| 17 | 233256-18-3 | [(1,1-DIMETHYLETHYL)AMINO]DIMETHYLSILANOL, METHANESULFONATE ESTER | C7H19NO3SSi | 225.38 | | |
| 18 | 233256-44-5 | Pyridine, 2-[[(4R)-4,5-dihydro-4-phenyl-2-oxazolyl]methyl]- | C15H14N2O | 238.28 | | |
| 19 | 233256-45-6 | Quinoline, 8-[(4R)-4,5-dihydro-4-phenyl-2-oxazolyl]- | C18H14N2O | 274.32 | | |
| 20 | 23326-27-4 | methyl but-2-ynoate | C5H6O2 | 98.1 | | |
| 21 | 23326-83-2 | 2,2,2-Trichloro-N-(2-nitrophenyl)acetamide | C8H5Cl3N2O3 | 283.5 | | |
| 22 | 233261-72-8 | 4-(4-CYANOPHENYL)-4-HYDROXYPIPERIDINE | C12H14N2O | 202.25 | | |
| 23 | 233261-74-0 | 4-(3,4-difluorophenyl)-4-piperidinol | C11H13F2NO | 213.22 | | |
| 24 | 233261-75-1 | 2,3,5,6-Tetrahydro-1H-[4,4'']bipyridinyl-4-ol | C10H14N2O | 178.23 | | |
| 25 | 233261-84-2 | 1-[(2-Chlorophenyl)sulfonyl]piperazine | C10H13ClN2O2S | 260.74 | 63～66℃ | |
| 26 | 233261-85-3 | 1-(3-Chloro-benzenesulfonyl)-piperazine | C10H13ClN2O2S | 260.74 | | |
| 27 | 2332611-95-5 | (-)-Mcl-1 inhibitor 22 | | | | |
| 28 | 2332611-98-8 | (+)-Mcl-1 inhibitor 22 | | | | |
| 29 | 233262-38-9 | mathemycin B | | | | |
| 30 | 233262-75-4 | 2-Methoxy-N-(2-methyl-1H-benzimidazol-7-yl)-4-[(2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl)carbonyl]benzamide | C27H26N4O3 | 454.52 | | |
| 31 | 233264-02-3 | FR-218944 | C28H30N4O6S | 550.63 | | |
| 32 | 233264-51-2 | 1H-Pyrido[3,4-b]azepine,2,3,4,5-tetrahydro-(9CI) | C9H12N2 | 148.21 | | |
| 33 | 233264-75-0 | 1H-Pyrido[4,3-b]azepine,2,3,4,5-tetrahydro-(9CI) | C9H12N2 | 148.21 | | |
| 34 | 233265-88-8 | BETA-OXO-BENZENEPROPANOIC ACID (4-NITROPHENYL)METHYL ESTER | C16H13NO5 | 299.281 | | |
| 35 | 233266-69-8 | L-Cysteine, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-, methyl ester | C19H19NO4S | 357.42 | | |
| 36 | 233266-76-7 | L-arabino-Pentodialdo-5,2-furanose, 4,5-O-(1-methylethylidene)-2-C-[(phenylmethoxy)methyl]-3-O-(phenylmethyl)-, (5R)- | C23H26O6 | 398.45 | | |
| 37 | 233266-77-8 | β-L-lyxo-Hex-5-enofuranose, 6,6-dibromo-5,6-dideoxy-1,2-O-(1-methylethylidene)-4-C-[(phenylmethoxy)methyl]-3-O-(phenylmethyl)- | C24H26Br2O5 | | | |
| 38 | 233266-80-3 | β-L-lyxo-Hex-5-ynofuranose, 5,6-dideoxy-1,2-O-(1-methylethylidene)-4-C-[(phenylmethoxy)methyl]-3-O-(phenylmethyl)-6-(triethylsilyl)- | C30H40O5Si | | | |
| 39 | 233266-82-5 | L-lyxo-Hex-5-ynofuranose, 5,6-dideoxy-4-C-[(phenylmethoxy)methyl]-3-O-(phenylmethyl)-6-(triethylsilyl)-, 1,2-diacetate | C31H40O7Si | | | |
| 40 | 233268-77-4 | 2-Butanone, 1,1'-[cyclohexylidenebis[(2-methyl-4,1-phenylene)oxy]]bis[3,3-dimethyl- | C32H44O4 | 492.69 | | |
| 41 | 233268-81-0 | 1,2-Propanediol, 3-[4-[1-ethyl-1-[4-(2-hydroxy-3,3-dimethylbutoxy)-3-methylphenyl]propyl]-2-methylphenoxy]- | C28H42O5 | 458.63 | | |
| 42 | 23327-57-3 | nefopam hydrochloride | C17H20ClNO | 289.8 | 238-242° | |
| 43 | 23327-71-1 | Propanoic acid, 2-hydrazino-, ethyl ester (9CI) | C5H12N2O2 | 132.16 | | |
| 44 | 233271-65-3 | Thiourea, N-(5-bromo-2-pyridinyl)-N'-[2-(2,5-dimethoxyphenyl)ethyl]- | C16H18BrN3O2S | 396.3 | | |
| 45 | 233271-89-1 | 3-Cyclohexene-1-carboxylicacid,1-hydroxy-5-oxo-,(1R)-(9CI) | C7H8O4 | 156.14 | | |
| 46 | 233272-35-0 | 5-NITRO-1,2,3,4-TETRAHYDRO-3-ISOQUINOLINECARBOXYLIC ACID | C10H10N2O4 | 222.2 | | |
| 47 | 233272-36-1 | 1-(7-NITRO-1,2,3,4-TETRAHYDROISOQUINOLIN-3-YL)ETHENOL | C10H10N2O4 | 222.2 | | |
| 48 | 233272-42-9 | 3-methyl-7-nitro-3,4-dihydro-2H-isoquinolin-1-one | C10H10N2O3 | 206.2 | | |
| 49 | 233272-56-5 | (Z)-1,1,1-trichloro-4-methoxyhex-3-en-2-one | C7H9Cl3O2 | 231.5 | | |
| 50 | 233272-89-4 | N-(prop-2-yn-1-yl)-4-(trifluoromethyl)aniline | C10H8F3N | 199.17 | | |
| 51 | 2332724-21-5 | Itopride Impurity 1 | C25H25NO7 | 451.47 | | |
| 52 | 233275-76-8 | MK 0343 | C19H17F2N7O | 397.38 | | |
| 53 | 233276-12-5 | 3-chloro-4-cyclobutyl-6-hydrazinylPyridazine | C8H11ClN4 | 198.65 | | |
| 54 | 233276-35-2 | (1s,3s)-3-(benzyloxy)cyclobutan-1-ol | C11H14O2 | 178.23 | | |
| 55 | 233276-38-5 | 2H-Pyran-4-carboxylicacid,tetrahydro-4-methyl-(9CI) | C7H12O3 | 144.17 | | |
| 56 | 233276-72-7 | ethyl 5-acetyl-3-amino-4-(4-methoxyphenyl)-6-methylthieno[2,3-b]pyridine-2-carboxylate | C20H20N2O4S | 384.4488 | | |
| 57 | 233276-73-8 | ethyl 5-acetyl-3-amino-4-(4-chlorophenyl)-6-methylthieno[2,3-b]pyridine-2-carboxylate | C19H17ClN2O3S | 388.86788 | | |
| 58 | 233277-99-1 | K777 | C32H38N4O4S | 574.73 | | |
| 59 | 233278-53-0 | 1,2,4-Triazolo[4,3-b]pyridazine, 6-chloro-7-cyclobutyl-3-phenyl- | C15H13ClN4 | 284.74 | | |
| 60 | 233278-54-1 | 3-CHLOROMETHYL-1-METHYL-1H-[1,2,4]TRIAZOLE | C4H6ClN3 | | | |
| 61 | 233278-56-3 | 5,6,7,8-Tetrahydro-[1,2,4]triazolo[1,5-a]pyrazine | C5H8N4 | 124.14 | | |
| 62 | 233279-24-8 | (-)-Thysanone | C14H12O6 | 276.24 | | |
| 63 | 233279-39-5 | Glycoborinine | C18H17NO2 | 279.33 | | |
| 64 | 23328-05-4 | Pregn-5-en-20-one,3-(methoxymethoxy)-, (3b)- (9CI) | C23H36O3 | 360.53014 | | |
| 65 | 23328-09-8 | Pregna-5,16-dien-20-one,3b-(trityloxy)- (8CI) | C40H44O2 | 556.77616 | | |
| 66 | 23328-10-1 | 21-Norchol-5-en-24-oicacid, 3b-hydroxy-23-methoxy-20-oxo-,methyl ester, acetate (8CI) | C27H40O6 | 460.6029 | | |
| 67 | 23328-11-2 | 21-Norchol-5-en-24-oicacid, 3b,23-dihydroxy-20-oxo-, methylester (8CI) | C24H36O5 | 404.53964 | | |
| 68 | 23328-12-3 | 21-Norchol-5-en-24-oicacid, 3b,23-dihydroxy-20-oxo-, methyl ester, diacetate (8CI) | C28H40O7 | 488.613 | | |
| 69 | 23328-16-7 | 21-Nor-5a-cholan-24-oic acid, 3b,23-dihydroxy-20-oxo- (8CI) | C23H36O5 | 392.52894 | | |
| 70 | 23328-17-8 | 21-Nor-5a-cholan-24-oic acid, 3b,23-dihydroxy-20-oxo-, methylester (8CI) | C24H38O5 | 406.55552 | | |
| 71 | 23328-18-9 | 21-Nor-5a-cholan-24-oic acid, 3b,23-dihydroxy-20-oxo-, methylester, diacetate (8CI) | C28H42O7 | 490.62888 | | |
| 72 | 23328-38-3 | 2,5-Hexanedione,3,3,4,4-tetramethyl- | C10H18O2 | 170.24872 | | |
| 73 | 23328-53-2 | UV571 | C25H35N3O | 393.56 | | |
| 74 | 23328-60-1 | 2-[2-(2-hydroxyethoxy)ethoxy]ethyl laurate | C18H36O5 | 332.48 | | |
| 75 | 23328-62-3 | 2-Methylthioacetaldehyde | C3H6OS | 90.14 | | |
| 76 | 23328-64-5 | 4-ethyl-2,6-dihydroxynicotinonitrile | C8H8N2O2 | 164.16132 | | |
| 77 | 23328-66-7 | 2,6-DI(OXIRAN-2-YLMETHYL)-1,2,3,5,6,7-HEXAHYDROPYRROLO[3,4-F]ISOINDOLE-1,3,5,7-TETRAONE | C16H12N2O6 | 328.28 | 215-217 °C | |
| 78 | 23328-69-0 | 4-chloromorpholine | C4H8ClNO | 121.57 | | |
| 79 | 23328-71-4 | STEAROXYPROPYLTRIMONIUM CHLORIDE | C21H44Cl3O | 418.93246 | | |
| 80 | 23328-87-2 | 2-Heptadecylimidazole | C20H38N2 | 306.53 | 89 °C | |
| 81 | 23328-88-3 | 2-bromo-5-methyl-1H-imidazole | C4H5BrN2 | 161 | 110-114 | |
| 82 | 23328-91-8 | Ethanone, 1-(4-methyl-1H-imidazol-5-yl)- | C6H8N2O | 124.14 | | |
| 83 | 233280-30-3 | 4-Chlorothiophene-2-Methanol | C5H5ClOS | 148.6106 | | |
| 84 | 2332803-84-4 | 10(9H)-Acridineacetic acid, 3-chloro-6-(1,1-dimethylethyl)-4-(methylthio)-9-oxo- | C20H20ClNO3S | 389.9 | | |
| 85 | 2332808-31-6 | Benzoic acid, 2-[[3-chloro-2-(methylthio)phenyl]amino]-4-(1,1-dimethylethyl)- | C18H20ClNO2S | 349.87 | | |
| 86 | 2332808-34-9 | 6-(tert-butyl)-3-chloro-4-(methylthio)acridin-9(10H)-one | | | | |
| 87 | 2332809-33-1 | 1-chloro-2-ethoxy-3-iodobenzene | C8H8ClIO | 282.51 | | |
| 88 | 233281-31-7 | Benzenemethanol, 3,4,5-tris(octadecyloxy)- | C61H116O4 | 913.57 | 72 °C(Solv: isopropanol (67-63-0)) | |
| 89 | 2332818-56-9 | 2-([1,1'-biphenyl]-2-yl)-4-(4-chlorophenyl)-6-phenyl-1,3,5-triazine | C27H18ClN3 | 419.90492 | | |
| 90 | 2332820-04-7 | 2332820-04-7 | C21H19F2N3O4 | 415.4 | | |
| 91 | 2332831-92-0 | TBAJ-5307 | C30H35BrN4O6 | 627.53 | | |
| 92 | 2332835-02-4 | PSB-1901 | C24H25BrN6O4S | 573.46 | | |
| 93 | 2332836-85-6 | 4-(Bromomethyl)-5-methoxy-2-(1-methylethoxy)pyridine | C10H14BrNO2 | 260.13 | | |
| 94 | 2332841-25-3 | 3-Quinolineethanol, 6-bromo-α-(2,6-dimethoxy-4-pyridinyl)-α-[2-(dimethylamino)ethyl]-2-methoxy-β-(2,3,6-trimethoxy-4-pyridinyl)-, (αS,βR)- | C31H37BrN4O7 | 657.55 | | |
| 95 | 2332841-83-3 | Pomstafib-2 | C52H66N2O20P2 | 1101.03 | | |
| 96 | 2332879-50-0 | 1-(6-bromo-4-fluoro-1H-benzo[d]imidazol-1-yl)-2-methylpropan-2-ol | | | | |
| 97 | 2332893-72-6 | 2-(Mesitylethynyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | C17H23BO2 | 270.18 | | |
| 98 | 2332897-85-3 | Nav1.1 activator 1 | C24H23F3N4O | 440.46 | | |
| 99 | 2332936-95-3 | Anticancer agent 11 | C20H21N3O2 | 335.4 | | |
| 100 | 2332943-95-8 | 4-bromo-7-fluoro-2,3-dihydro-1H-indene | C9H8BrF | 215.06 | | |
| 101 | 2332972-26-4 | Recombinant Human Cyclin-Dependent Kinase Inhibitor 2A | C24H22FNO4S | 439.5 | | |
| 102 | 2332972-44-6 | 5H-Thieno[2,3-c]pyran-3-carboxylic acid, 4,7-dihydro-2-iodo-, ethyl ester | C10H11IO3S | 338.16 | | |